Kim, J.W., Seo, H.S., Park, J.H., Na, J.O., Choi, C.U., Lim, H.E., Kim, E.J., Rha, S.-W., et al. (2009) A prospective randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimusversus a sirolimus-eluting stent. Journal of the American College of Cardiology, 53, 1653-1659. doi:10.1016/j.jacc.2009.01.051

has been cited by the following article:

• TITLE: Clinical significance of provoked coronary spasm at chronic stage in patients who underwent successful complete coronary revascularization with first-generation drug-eluting stents

  AUTHORS: Shigenori Ito, Kosuke Nakasuka, Satoru Sekimoto, Kazuyuki Miyata, Masahiko Inomata, Takayuki Yoshida, Nozomu Tamai, Tomoaki Saeki, Shin Suzuki, Yoshimasa Murakami, Akihiro Morino, Yoshiyuki Shimizu, Koichi Sato

  KEYWORDS: Drug-Eluting Stent; Follow-Up Studies; Percutaneous Coronary Intervention; Acetylcholine; Cardiovascular Event

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.3 No.4A, July 12, 2013

  ABSTRACT: Background: Provoked spasm might have influence on cardiovascular events even after successful DES implantation. Methods and results: A consecutive 122 patients who underwent first-generation DES (CypherTM, and TaxusTM) implantation and had no residual stenosis at follow-up coronary angiography were included. All patients also underwent acetylcholine provocation test (ACh) at follow-up angiography. Age, sex, coronary risk factors (smoking, hypertension, diabetes mellitus, dyslipidemia), medication (calcium channel blockers, angiotensin receptor blockers, angiotensin converting enzyme inhibitors, nitrates, β blockers, statins), duration from stent implantation to follow-up angiography (15.5 ± 14.5 months), old myocardial infarction, Ach + were included as variables for multivariate analysis for cardiovascular events (angina pectoris without intervention, target lesion revascularization, acute myocardial infarction, definite or probable stent thrombosis, cardiac death, and stroke). ACh provocation test was positive in 64.8%. The following events occurred during a mean follow-up period of 26.9 ± 9.5 months; angina pectoris without intervention in 12, very late stent thrombosis in 1, acute myocardial infarction in 1, sudden death in 1, and stroke in 4. By Adjusted Cox hazard model, age was the independent predictor of future cardiovascular events. ACh was unbalanced data for Cox hazard model, and by logistic regression model, ACh was the strongest predictor. Conclusions: Coronary endothelial dysfunction at chronic stage is the strongest predictor of further prognosis in patients with first-generation DES.